Patent · US Active

Quinoxalinones and dihydroquinoxalinones as respiratory syncytial virus antiviral agents

US10501445B2 · kind B2 · utility

0Cited by

0References

18Claims

0Family size

Assignee

Janssen Sciences Ireland UC · IE

Inventors

Abdellah Tahri · Anderlecht, BE
Tim Hugo Maria Jonckers · Heist-op-den-Berg, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE
Samuël Dominique Demin · Ekeren, BE

Key dates

Filing date	Sep 24, 2018
Grant date	Dec 10, 2019
Priority date	—
Expiry date	Sep 24, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D519/00
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Quinoxalinones and dihydroquinoxalinones having inhibitory activity on RSV replication and having the formula I including addition salts, and stereochemically isomeric forms thereof; compositions containing these compounds as active ingredient and processes for preparing these compounds and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.